Pfizer is trying to find US approval of the booster dose of its two-shot COVID-19 vaccine. The drugmaker reported Wednesday that it has began the appliance approach for a third dose of its vaccine for individuals ages 16 and more mature. The business stated it will finish the applying With http://web.es.nccu.edu.tw/class/netlink/hits.php?id=269&url=https://getlisting.org/